Nektar Therapeutics (NKTR) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for NKTR. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 234 institutions reported holding NKTR, with 35.9 million shares worth $2.5 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR | 5,067,920 | $354M | INCREASED |
| Two Seas Capital | 3,092,234 | $216M | INCREASED |
| BlackRock | 2,941,851 | $205M | INCREASED |
| Bvf Inc/IL | 2,391,075 | $167M | DECREASED |
| Vanguard | 2,131,090 | $149M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Roy A Whitfield (Director) | AWARD | 4,000 | $231K | 2026-09-23 |
| Roy A Whitfield (Director) | AWARD | 2,000 | 2026-09-23 | |
| Scott R Greer (Director) | AWARD | 4,000 | $231K | 2026-09-23 |
| Scott R Greer (Director) | AWARD | 2,000 | 2026-09-23 | |
| Robert Chess (Director) | AWARD | 4,000 | $231K | 2026-09-23 |
Full institutional holdings, insider history, and congressional trades for Nektar Therapeutics on SentiSense.